Support the FIND Act

The bi-partisan Facilitating Innovative Nuclear Diagnostics (FIND) Act will ensure patient access to these imaging procedures. 

Act Now!

2024 THERAPEUTICS CONFERENCE SEPT 19‑21 REGISTRATION NOW OPEN

Don’t Wait! Early-Bird Rates End August 1
Learn from the experts. Connect with colleagues. Gain invaluable insights on the latest developments in the field.

Register Now!

SNMMI News Explore All News

Novel PET Imaging Tool Identifies Early Signs of Inflammatory Bowel Disease and Predicts Response to

A newly developed imaging method, granzyme B PET, can non-invasively detect inflammatory bowel disease (IBD) and provide a real-time picture of active inflammation in the tissue, according to new research published in the July issue of JNM.

Lower Dose Prostate Cancer Treatments Retain Efficacy While Improving Tolerability

Two reduced dose radiopharmaceutical therapy approaches for advanced stage metastatic castrate-resistant prostate cancer have been shown to be just as effective as the standard dose, according to new research published in the July issue of JNM.

JNM Maintains Strong Metrics in 2023 Journal Citation Reports

The Journal of Nuclear Medicine—the flagship publication of the SNMMI—has maintained its status as one of the top medical imaging journals worldwide, according to new data released in Clarivate's 2023 Journal Citation Reports.

Latest Journals